NEPHROS INC (NEPH) Fundamental Analysis & Valuation

NASDAQ:NEPH • US6406714005

3.91 USD
+0.09 (+2.36%)
Last: Mar 5, 2026, 03:52 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This NEPH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

NEPH gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 130 industry peers in the Machinery industry. NEPH has an excellent financial health rating, but there are some minor concerns on its profitability. NEPH has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. NEPH Profitability Analysis

1.1 Basic Checks

  • In the past year NEPH was profitable.
  • NEPH had a positive operating cash flow in the past year.
  • NEPH had negative earnings in 4 of the past 5 years.
  • In the past 5 years NEPH reported 4 times negative operating cash flow.
NEPH Yearly Net Income VS EBIT VS OCF VS FCFNEPH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2M -4M -6M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 11.18%, NEPH belongs to the top of the industry, outperforming 85.38% of the companies in the same industry.
  • The Return On Equity of NEPH (14.80%) is better than 75.38% of its industry peers.
  • The Return On Invested Capital of NEPH (11.15%) is better than 78.46% of its industry peers.
Industry RankSector Rank
ROA 11.18%
ROE 14.8%
ROIC 11.15%
ROA(3y)-26.57%
ROA(5y)-25.75%
ROE(3y)-50%
ROE(5y)-44.65%
ROIC(3y)N/A
ROIC(5y)N/A
NEPH Yearly ROA, ROE, ROICNEPH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

  • Looking at the Profit Margin, with a value of 8.26%, NEPH is in the better half of the industry, outperforming 66.92% of the companies in the same industry.
  • NEPH's Operating Margin of 8.06% is in line compared to the rest of the industry. NEPH outperforms 49.23% of its industry peers.
  • NEPH has a better Gross Margin (63.24%) than 98.46% of its industry peers.
  • In the last couple of years the Gross Margin of NEPH has remained more or less at the same level.
Industry RankSector Rank
OM 8.06%
PM (TTM) 8.26%
GM 63.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.79%
GM growth 5Y0.91%
NEPH Yearly Profit, Operating, Gross MarginsNEPH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. NEPH Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so NEPH is still creating some value.
  • The number of shares outstanding for NEPH remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, NEPH has more shares outstanding
  • NEPH has a worse debt/assets ratio than last year.
NEPH Yearly Shares OutstandingNEPH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
NEPH Yearly Total Debt VS Total AssetsNEPH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

  • Based on the Altman-Z score of -5.16, we must say that NEPH is in the distress zone and has some risk of bankruptcy.
  • NEPH has a worse Altman-Z score (-5.16) than 82.31% of its industry peers.
  • NEPH has a debt to FCF ratio of 0.01. This is a very positive value and a sign of high solvency as it would only need 0.01 years to pay back of all of its debts.
  • NEPH has a Debt to FCF ratio of 0.01. This is amongst the best in the industry. NEPH outperforms 93.08% of its industry peers.
  • NEPH has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of NEPH (0.00) is better than 84.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z -5.16
ROIC/WACC1.22
WACC9.13%
NEPH Yearly LT Debt VS Equity VS FCFNEPH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

  • A Current Ratio of 4.34 indicates that NEPH has no problem at all paying its short term obligations.
  • The Current ratio of NEPH (4.34) is better than 87.69% of its industry peers.
  • NEPH has a Quick Ratio of 3.23. This indicates that NEPH is financially healthy and has no problem in meeting its short term obligations.
  • NEPH has a better Quick ratio (3.23) than 87.69% of its industry peers.
Industry RankSector Rank
Current Ratio 4.34
Quick Ratio 3.23
NEPH Yearly Current Assets VS Current LiabilitesNEPH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. NEPH Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 244.44% over the past year.
  • The Revenue has grown by 32.36% in the past year. This is a very strong growth!
  • NEPH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.51% yearly.
EPS 1Y (TTM)244.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)32.36%
Revenue growth 3Y11.49%
Revenue growth 5Y6.51%
Sales Q2Q%35.42%

3.2 Future

  • Based on estimates for the next years, NEPH will show a very strong growth in Earnings Per Share. The EPS will grow by 39523200.00% on average per year.
  • The Revenue is expected to grow by 18.15% on average over the next years. This is quite good.
EPS Next Y3233944820422206000%
EPS Next 2Y20999820744.76%
EPS Next 3Y39523200%
EPS Next 5YN/A
Revenue Next Year33.54%
Revenue Next 2Y22.44%
Revenue Next 3Y18.15%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NEPH Yearly Revenue VS EstimatesNEPH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M 20M
NEPH Yearly EPS VS EstimatesNEPH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 -0.4 -0.6

More info and screens

Find the best growth stocksShow best growing peers

5

4. NEPH Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 30.08, NEPH can be considered very expensive at the moment.
  • NEPH's Price/Earnings is on the same level as the industry average.
  • NEPH is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.03, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 25.56 indicates a quite expensive valuation of NEPH.
  • The rest of the industry has a similar Price/Forward Earnings ratio as NEPH.
  • The average S&P500 Price/Forward Earnings ratio is at 25.11. NEPH is around the same levels.
Industry RankSector Rank
PE 30.08
Fwd PE 25.56
NEPH Price Earnings VS Forward Price EarningsNEPH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NEPH indicates a slightly more expensive valuation: NEPH is more expensive than 64.62% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, NEPH is valued cheaply inside the industry as 86.92% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 15.29
EV/EBITDA 22.34
NEPH Per share dataNEPH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

  • NEPH's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • NEPH's earnings are expected to grow with 39523200.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)0
PEG (5Y)N/A
EPS Next 2Y20999820744.76%
EPS Next 3Y39523200%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NEPH Dividend Analysis

5.1 Amount

  • NEPH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NEPH Fundamentals: All Metrics, Ratios and Statistics

NEPHROS INC

NASDAQ:NEPH (3/5/2026, 3:52:51 PM)

3.91

+0.09 (+2.36%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)11-06
Earnings (Next)03-05
Inst Owners47.19%
Inst Owner Change5.29%
Ins Owners10.85%
Ins Owner Change0.7%
Market Cap41.56M
Revenue(TTM)17.93M
Net Income(TTM)1.48M
Analysts82.5
Price Target7.14 (82.61%)
Short Float %0.11%
Short Ratio0.21
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)212.75%
Min EPS beat(2)178.43%
Max EPS beat(2)247.06%
EPS beat(4)4
Avg EPS beat(4)450.49%
Min EPS beat(4)178.43%
Max EPS beat(4)1080.39%
EPS beat(8)6
Avg EPS beat(8)227.45%
EPS beat(12)8
Avg EPS beat(12)151.69%
EPS beat(16)10
Avg EPS beat(16)98.99%
Revenue beat(2)2
Avg Revenue beat(2)19.73%
Min Revenue beat(2)18.66%
Max Revenue beat(2)20.79%
Revenue beat(4)4
Avg Revenue beat(4)19.17%
Min Revenue beat(4)6.29%
Max Revenue beat(4)30.93%
Revenue beat(8)4
Avg Revenue beat(8)4.24%
Revenue beat(12)6
Avg Revenue beat(12)3.61%
Revenue beat(16)7
Avg Revenue beat(16)0.06%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)144.44%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)7.19%
Valuation
Industry RankSector Rank
PE 30.08
Fwd PE 25.56
P/S 2.32
P/FCF 15.29
P/OCF 15.29
P/B 4.15
P/tB 4.75
EV/EBITDA 22.34
EPS(TTM)0.13
EY3.32%
EPS(NY)0.15
Fwd EY3.91%
FCF(TTM)0.26
FCFY6.54%
OCF(TTM)0.26
OCFY6.54%
SpS1.69
BVpS0.94
TBVpS0.82
PEG (NY)0
PEG (5Y)N/A
Graham Number1.66
Profitability
Industry RankSector Rank
ROA 11.18%
ROE 14.8%
ROCE 13.4%
ROIC 11.15%
ROICexc 21.42%
ROICexgc 27.63%
OM 8.06%
PM (TTM) 8.26%
GM 63.24%
FCFM 15.16%
ROA(3y)-26.57%
ROA(5y)-25.75%
ROE(3y)-50%
ROE(5y)-44.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.79%
GM growth 5Y0.91%
F-Score7
Asset Turnover1.35
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA 0.01
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 722.5
Cash Conversion 171.33%
Profit Quality 183.59%
Current Ratio 4.34
Quick Ratio 3.23
Altman-Z -5.16
F-Score7
WACC9.13%
ROIC/WACC1.22
Cap/Depr(3y)38.4%
Cap/Depr(5y)49.1%
Cap/Sales(3y)0.77%
Cap/Sales(5y)1.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)244.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y3233944820422206000%
EPS Next 2Y20999820744.76%
EPS Next 3Y39523200%
EPS Next 5YN/A
Revenue 1Y (TTM)32.36%
Revenue growth 3Y11.49%
Revenue growth 5Y6.51%
Sales Q2Q%35.42%
Revenue Next Year33.54%
Revenue Next 2Y22.44%
Revenue Next 3Y18.15%
Revenue Next 5YN/A
EBIT growth 1Y250.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y208.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y208.98%
OCF growth 3YN/A
OCF growth 5YN/A

NEPHROS INC / NEPH FAQ

What is the fundamental rating for NEPH stock?

ChartMill assigns a fundamental rating of 5 / 10 to NEPH.


Can you provide the valuation status for NEPHROS INC?

ChartMill assigns a valuation rating of 5 / 10 to NEPHROS INC (NEPH). This can be considered as Fairly Valued.


Can you provide the profitability details for NEPHROS INC?

NEPHROS INC (NEPH) has a profitability rating of 4 / 10.


What are the PE and PB ratios of NEPHROS INC (NEPH) stock?

The Price/Earnings (PE) ratio for NEPHROS INC (NEPH) is 30.08 and the Price/Book (PB) ratio is 4.15.


How financially healthy is NEPHROS INC?

The financial health rating of NEPHROS INC (NEPH) is 7 / 10.